Vnitr Lek 2008, 54(12):1171-1173

Léčba invazivních mykotických infekcí u imunoalterovaných nemocných - doporučení odborných společností

J. Haber1,*, J. Mayer2, L. Drgoňa3
1 I. interní klinika - hematoonkologická 1. lékařské fakulty UK a VFN Praha, přednosta doc. MUDr. Marek Trněný, CSc.
2 Interní hematoonkologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jiří Vorlíček, CSc.
3 Národný onkologický ústav Bratislava, Slovenská republika, riaditeľ prof. MUDr. Ivan Koza, CSc.

Received: August 12, 2008; Published: December 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Haber J, Mayer J, Drgoňa L. Léčba invazivních mykotických infekcí u imunoalterovaných nemocných - doporučení odborných společností. Vnitr Lek. 2008;54(12):1171-1173.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cordonnier C, Calandra T. The first European conference on infections in leukaemia: Why and how? Eur J Cancer Suppl 2007; 5: 2-4. Go to original source...
    2. Kish MA. Guide to development of practice guidelines. Clin Infect Dis 2001; 32: 851-854. Go to original source... Go to PubMed...
    3. Dykewicz CA. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. Clin Infect Dis 2001; 33: 139-144. Go to original source... Go to PubMed...
    4. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14. Go to original source... Go to PubMed...
    5. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.